Yew Bio-Pharm Group, Inc. Current Foreign Tax Expense (Benefit)
Yew Bio-Pharm Group, Inc. reported Current Foreign Tax Expense (Benefit) of $27.97 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-30.
Discontinued › Expense Statement › Income Tax
us-gaap:CurrentForeignTaxExpenseBenefit · last filed 2021-03-30
- Yew Bio-Pharm Group, Inc. current foreign tax expense (benefit) for fiscal 2020 was $27.97K, a 32.53% increase from fiscal 2019.
- Yew Bio-Pharm Group, Inc. current foreign tax expense (benefit) for fiscal 2019 was $21.10K, a 5895.17% increase from fiscal 2018.
- Yew Bio-Pharm Group, Inc. current foreign tax expense (benefit) for fiscal 2018 was $352.00.
| Period end | Current Foreign Tax Expense (Benefit) 12 month |
|---|---|
| 2020-12-31 | $27.97K 10-K · filed 2021-03-30 |
| 2019-12-31 | $21.10K 10-K · filed 2021-03-30 |
| 2018-12-31 | $352.00 10-K · filed 2020-05-14 |